Skip to content
Colorectal Cancer Clinical Trials

Phoenix, Arizona

Colorectal cancer clinical trials in Phoenix, AZ

28 colorectal cancer studies are recruiting participants at sites in Phoenix as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Phoenix at a glance

  • 28 studies are recruiting at a site in Phoenix.
  • By phase: Phase 1 (8), Phase 1/2 (4), Phase 2 (3), Phase 2/3 (1), Phase 3 (5), No phase (3), Observational (4). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (16), university, hospital or other (11), government (1).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Phoenix

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Study site
    Banner-University Medical Center Phoenix
    Registry record
    NCT05863195 · updated
  2. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Mayo Clinic - Arizona ( Site 0090)
    Registry record
    NCT06997497 · updated
  3. Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study site
    Cancer Center at Saint Joseph's
    Registry record
    NCT07018869 · updated
  4. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Cancer Center at Saint Joseph's
    Registry record
    NCT05080673 · updated
  5. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Cancer Center at Saint Joseph's
    Registry record
    NCT05174169 · updated
  6. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Cancer Center at Saint Joseph's
    Registry record
    NCT05334069 · updated
  7. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study site
    Cancer Center at Saint Joseph's
    Registry record
    NCT06418204 · updated
  8. Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Cancer Center at Saint Joseph's
    Registry record
    NCT07283939 · updated
  9. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Mayo Clinic Hospital in Arizona
    Registry record
    NCT05673148 · updated
  10. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Mayo Clinic, Phoenix
    Registry record
    NCT06720987 · updated
  11. Family Communications After Genetic Testing

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Cancer Center at Saint Joseph's
    Registry record
    NCT07143487 · updated
  12. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    A2 Biotherapeutics Inc.
    Study site
    Mayo Clinic Hospital
    Registry record
    NCT04981119 · updated
  13. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    Mayo Clinic Comprehensive Cancer Center
    Registry record
    NCT06026410 · updated
  14. Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Ironwood Cancer & Research Centers · Mayo Clinic Building- Phoenix · Mayo Clinic Hospital
    Registry record
    NCT07222800 · updated
  15. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT05919264 · updated
  16. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study site
    Exelixis Clinical Site #67
    Registry record
    NCT05176483 · updated
  17. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Mayo Clinic Hospital
    Registry record
    NCT06445062 · updated
  18. An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Mayo Clinic Hospital in Arizona
    Registry record
    NCT06557733 · updated
  19. A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cartography Biosciences
    Study site
    Mayo Clinic Arizona
    Registry record
    NCT07321106 · updated
  20. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Xencor, Inc.
    Study site
    Xencor Investigative Site
    Registry record
    NCT05433142 · updated
  21. Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MOMA Therapeutics
    Registry record
    NCT06974110 · updated
  22. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study site
    Mayo Clinic Hospital
    Registry record
    NCT06131840 · updated
  23. A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Study site
    Mayo Clinic Hospital
    Registry record
    NCT06179160 · updated
  24. A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Ono Pharmaceutical Co., Ltd.
    Study site
    Mayo Clinic Arizona
    Registry record
    NCT06948448 · updated
  25. Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Canadian Cancer Trials Group
    Study site
    Cancer Center at Saint Joseph's
    Registry record
    NCT06205485 · updated
  26. A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alentis Therapeutics AG
    Study site
    Mayo Clinic Comprehensive Cancer Center
    Registry record
    NCT07169734 · updated
  27. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    858 Therapeutics, Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT06395519 · updated
  28. Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Arizona
    Registry record
    NCT06349642 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Phoenix, AZ on ClinicalTrials.gov.

Ask about studies near Phoenix

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call